Pharming Group NV (OTCMKTS:PHGUF – Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $1.70, but opened at $1.51. Pharming Group shares last traded at $1.51, with a volume of 1,000 shares.
Pharming Group Stock Performance
The stock has a fifty day moving average of $1.78 and a two-hundred day moving average of $1.61. The company has a current ratio of 3.16, a quick ratio of 2.39 and a debt-to-equity ratio of 0.46.
About Pharming Group
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
Featured Stories
- Five stocks we like better than Pharming Group
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump Planning to Use Public Law 63-43: Prepare Now
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
